Abstract 1448: Deep learning integration of molecular and histopathological data for prognostic stratification in non small cell lung cancer.

Abstract Background: Co-mutations, PD-L1 and TILs are key NSCLC biomarkers. We applied deep learning to a multimodal patient cohort to identify prognostic patterns integrating morphology, mutations, and clinical features. Methods: 367 NSCLC patients from 18 Hellenic Cooperative Oncology Group-affiliated centers were retrospectively assessed for PD-L1 status (Dako 22C3 pharmDx), TILs (H&E slides), and somatic pathogenic variants with a 38-gene next-generation sequencing (NGS) panel. Whole slide images (WSI) were digitized by an optical microscope scanner. Ten pathology foundation models were benchmarked for predicting mutation, co-mutation, PD-L1 and TILs status. Mutated genes with >5% prevalence were considered for mutation and co-mutation endpoints (TP53, KRAS, STK11, PTEN, EGFR). A vision transformer model was trained on WSI features to predict endpoints and evaluate AUROC. Kaplan-Meier analysis assessed prognostic relevance of models and top feature tiles from model attention maps provided morphological explainability. The STAMP digital pathology pipeline supported feature extraction and model training. Results: Single mutation models yielded AUROC scores of 0.6-0.85, with STK11 prediction from HOptimus1 features highest. Co-mutation models produced AUROC scores of 0.69-0.77 with EGFR-TP53 prediction from Uni2 features the best. The KRAS-TP53 co-mutation model (AUROC 0.69, Uni2) showed significant separation in overall survival curves (p=0.05) between classes. Best-performing PD-L1 and TIL models also demonstrated significant survival separation (p=0.005 and p=0.05). Conclusion: Findings demonstrate the potential of pathology foundation models to derive complex clinically-relevant prognostic models for NSCLC with multimodal explainability. Citation Format: Sanddhya Jayabalan, Konstantinos Efthymiadis, Alexia Eliades, Kyriaki Papadopoulou, Abraham Pouliakis, Elena Fountzilas, Sofia Lampaki, Mattheos Bobos, Anna Goussia, Soultana Meditskou, Konstantinos Kyritsis, Helena Linardou, George Pentheroudakis, Dimitrios Bafaloukos, Dimitrios Pectasides, Epaminondas Samantas, Zunamys I. Carrero, George Fountzilas, Jakob N. Kather. Deep learning integration of molecular and histopathological data for prognostic stratification in non small cell lung cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1448.

Authors

Institutions

Publication Details

Journal
Cancer Research
Published
2026-04-03
DOI
https://doi.org/10.1158/1538-7445.am2026-1448
Primary Topic
Radiomics and Machine Learning in Medical Imaging
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Abstract 1448: Deep learning integration of molecular and histopathological data for prognostic stratification in non small cell lung cancer.

Helena Linardou, Kyriaki Papadopoulou, Mattheos Bobos, Konstantinos Efthymiadis et al.
Cancer Research
Radiomics and Machine Learning in Medical Imaging
article

Abstract 1448: Deep learning integration of molecular and histopathological data for prognostic stratification in non small cell lung cancer.

Helena Linardou, Kyriaki Papadopoulou, Mattheos Bobos, Konstantinos Efthymiadis, Abraham Pouliakis, George E. Pentheroudakis, Soultana Meditskou, Sofia Lampaki, ANNA C. GOUSSIA, George Fountzilas, Konstantinos Kyritsis, Zunamys I. Carrero, Alexia Eliades, Elena Fountzilas, Sanddhya Jayabalan, Dimitrios I. Bafaloukos, D. Pectasides, Epaminondas Samantas, Jakob Nikolas Kather
article en

Abstract

Abstract Background: Co-mutations, PD-L1 and TILs are key NSCLC biomarkers. We applied deep learning to a multimodal patient cohort to identify prognostic patterns integrating morphology, mutations, and clinical features. Methods: 367 NSCLC patients from 18 Hellenic Cooperative Oncology Group-affiliated centers were retrospectively assessed for PD-L1 status (Dako 22C3 pharmDx), TILs (H&E slides), and somatic pathogenic variants with a 38-gene next-generation sequencing (NGS) panel. Whole slide images (WSI) were digitized by an optical microscope scanner. Ten pathology foundation models were benchmarked for predicting mutation, co-mutation, PD-L1 and TILs status. Mutated genes with >5% prevalence were considered for mutation and co-mutation endpoints (TP53, KRAS, STK11, PTEN, EGFR). A vision transformer model was trained on WSI features to predict endpoints and evaluate AUROC. Kaplan-Meier analysis assessed prognostic relevance of models and top feature tiles from model attention maps provided morphological explainability. The STAMP digital pathology pipeline supported feature extraction and model training. Results: Single mutation models yielded AUROC scores of 0.6-0.85, with STK11 prediction from HOptimus1 features highest. Co-mutation models produced AUROC scores of 0.69-0.77 with EGFR-TP53 prediction from Uni2 features the best. The KRAS-TP53 co-mutation model (AUROC 0.69, Uni2) showed significant separation in overall survival curves (p=0.05) between classes. Best-performing PD-L1 and TIL models also demonstrated significant survival separation (p=0.005 and p=0.05). Conclusion: Findings demonstrate the potential of pathology foundation models to derive complex clinically-relevant prognostic models for NSCLC with multimodal explainability. Citation Format: Sanddhya Jayabalan, Konstantinos Efthymiadis, Alexia Eliades, Kyriaki Papadopoulou, Abraham Pouliakis, Elena Fountzilas, Sofia Lampaki, Mattheos Bobos, Anna Goussia, Soultana Meditskou, Konstantinos Kyritsis, Helena Linardou, George Pentheroudakis, Dimitrios Bafaloukos, Dimitrios Pectasides, Epaminondas Samantas, Zunamys I. Carrero, George Fountzilas, Jakob N. Kather. Deep learning integration of molecular and histopathological data for prognostic stratification in non small cell lung cancer [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2026; Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 1448.

Cancer ResearchVol. 86(7_Supplement)
National and Kapodistrian University of Athens (GR), Hellenic Agency for Local Development and Local Government (GR), Hellenic Cooperative Oncology Group (GR), Cyprus Institute of Neurology and Genetics (CY), Technische Universität Dresden (DE)
Openalex Percentile: Top 26%
Radiomics and Machine Learning in Medical Imaging
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.